Top CRO`s in Clinical Trials

Top CRO`s in Clinical Trials

To rank the best CROs, a study was conducted by CenterWatch, an independent global benchmarking organization for clinical trials. The study consists of survey responses from more than 3,700 clinical trial site representatives. It includes ratings of Top CRO`s based on performance-related attributes and overall reputation.

Vial CRO

Vial CRO is a dermatology-focused contract research organization (CRO) that will provide dermatology clinical trials to pharmaceutical companies and academic institutions. Vial’s executive team includes Dr. Betsey Zbyszynski, Head of Clinical Operations and Jason Shuris, Head of Sales. In addition, the company will welcome Dr. Janet DuBois, Principal Researcher at DermResearch, in Austin, Texas. These individuals have combined experience of more than one hundred years in dermatology clinical trials. Vial CRO will also be backed by the Vial Clinic Network, which includes over 35 dermatology clinical research sites worldwide.

Vial has also added several new members to its scientific advisory board. Dr. Arati Rao will advise the company on its oncology CRO. The company also expanded its scientific advisory board with three new members. With these additions, Vial is positioned to expand its client base in oncology.

Top CRO`s in Clinical Trials

Vial’s team has extensive experience in patient recruitment. Its marketing team has worked with $10 billion+ consumer companies and has developed an unparalleled patient recruitment engine. Vial’s pre-screening call center engages highly qualified subjects with the goal of achieving enrollment targets. Its team is dedicated to meeting all client needs and expectations.

Vial’s dermatology CRO is powered by its network of over 35 dermatology clinics across the United States and is focused on bringing dermatology trials to a wider patient base. Vial claims that the network’s unique patient recruitment engine will ensure higher quality trials with shorter trial durations.

Covance

Covance is one of the world’s largest contract research organizations (CROs), with annual revenues of more than $2 billion. The company was founded in 1968 as an environmental sciences corporation, but rebranded in 1996 as Covance. It provides nonclinical, preclinical, clinical, and commercialization services to the pharmaceutical industry. With subsidiaries across the globe, Covance employs more than 50,000 people. The company’s mission is to test new medical treatments before they are licensed and introduced into the market.

The rankings are based on market capitalization, which is derived from financial reports and corporate documents. As of August 30, 2018, there were eight CROs with revenues in the billions. Covance, IQVIA, and Eurofins each had over $7 billion in revenue. Other top CROs included Syneos, PPD, and Medpace.

IQVIA

IQVIA is one of the top CROs in the industry. Last year, it was ranked as one of the best by site representatives in a survey conducted by WCG CenterWatch. It is now one of the top CROs in the world in terms of reputation.

IQVIA is a global leader in clinical research and advanced analytics. In its recent merger with IMS Health, the company has built an end-to-end clinical service for clients. It has also acquired several smaller specialty companies. IQVIA is also the top CRO in Overall Reputation by clinical trial sites, according to the WCG CenterWatch Global Site Relationship Benchmark Survey Report for 2021.

The company has more than forty locations around the world and offers a wide range of services for clients. The company’s portfolio includes clinical development, commercialisation and consulting services across multiple therapeutic areas. Recently, it partnered with Genomics England on the 100,000 Genomes Project and IBM Watson to support oncology research. Since then, it has expanded its service offering in the oncology and genomic sciences sectors.

Top CRO`s in Clinical Trials

Syneos Health

Syneos Health is an end-to-end integrated biopharmaceutical solutions organization with more than 110 offices across the globe. Its services include contract research, contract manufacturing, and contract commercialisation, and it offers a range of fit-for-purpose solutions for Phase I to IV clinical trials. In addition, it offers consulting services to clients.

The company has recently updated its guidance through June 2020. The guidance shows reasonably strong Q1 results, a modest 2q contraction, and a margin of 13-14%. This guidance is reasonable, and it’s worth paying attention to. However, it’s important to note that Syneos’s guidance is heavily based on like-for-like comparisons between the third quarters of fiscal years ending in FYE2019 and three quarters earlier.

Syneos Health has outlined its growth strategy for FY2020 and FYE2021, and has launched an aggressive margin enhancement program. This program is designed to reduce the impact of COVID-19 on the company. Its long-term plans include penetrating the large pharma market and increasing its share of the SMID market. However, this approach poses risks due to lower venture funding under COVID-19.

To rank the best CROs, a study was conducted by CenterWatch, an independent global benchmarking organization for clinical trials. The study consists of survey responses from more than 3,700 clinical trial site representatives. It includes ratings of Top CRO`s based on performance-related attributes and overall reputation. Vial CRO Vial CRO is a dermatology-focused contract research…

To rank the best CROs, a study was conducted by CenterWatch, an independent global benchmarking organization for clinical trials. The study consists of survey responses from more than 3,700 clinical trial site representatives. It includes ratings of Top CRO`s based on performance-related attributes and overall reputation. Vial CRO Vial CRO is a dermatology-focused contract research…